What is Antidepressants Parkinson's Disease Phase 3 Clinical Trial?
CATEGORY:
Antidepressants Parkinson's Disease Phase 3 Clinical Trial is a randomized double blind study to determine the effectiveness of escitalopram, nortriptyline, or placebo for the treatment of depression in Parkinson's Disease. Identifier: NCT03652870
Save up to 80% off your prescriptions!
We currently don't have enough shared data that is made public for this treatment.
Let's build this page together! When you share what it's like to have Antidepressants Parkinson's Disease Phase 3 Clinical Trial through your profile, those stories and data appear here too.
Last updated: